Aubin É, Paquin Proulx D, Trépanier P, Lemieux R, Bazin R. (2011). Prevention of T cell activation by interference of internalized intravenous immunoglobulin (IVIg) with MHC II-dependent native antigen presentation. Clin Immunol (Clinical Immunology) 141 (3): 273-283.
Samson M, Jung D. (2011). Intracellular trafficking and fate of chimeric adenovirus 5/F35 in human B lymphocytes. J Gene Med (The Journal of Gene Medicine) 13 (09): 451-461.
Padet L, St-Amour I, Aubin É, Bazin R. (2011). Neutralization of mitogenic lectins by IVIg prevents T cell activation: Does IVIg really have a direct effect on T cells? Clin Exp Immunol (Clinical & Experimental Immunology) 166 (3): 352-360.
Çelebi B, Mantovani D, Pineault N. (2011). Effects of extracellular matrix proteins on the growth of haematopoietic progenitor cells. Biomed Mater (Biomedical Materials) 6 (5): 055011.
Néron S, Côté G, Dumont N, Roy A, Fecteau JF, McNeil MÈ. (2011). Contribution of CD40-activated naïve B lymphocytes in the modulation of CD27+ memory B cell growth and differentiation. Dans : Advances in Medicine and Biology, vol. 25. Bernhardt, LV, éditeur de la collection (Hauppauge, NY, Nova Science Publishers, Inc., 306 p.): 143-167.
Pineault N, Boyer L. (2011). Cellular based therapies to prevent or reduce thrombocytopenia. Transfusion (Transfusion) 51 (s4): 72S-81S.
Dussault N, Dumont N, Néron S. (2011). Modulation of human B lymphocyte differentiation by therapeutic immunoglobulins: from protein to mRNA levels. Open Journal of Immunology (Open Journal of Immunology) 1 (03): 65-73.
Néron S, Roy A, Dumont N, Dussault N. (2011). Effective in vitro expansion of CD40-activated human B lymphocytes in a defined bovine protein-free medium. J Immunol Methods (Journal of Immunological Methods) 371 (1-2): 61-69.
Delage G, Thibault L, Strobl F. (2011). Workflow analysis and performance evaluation of an automated blood testing system. IVD Technology (IVD Technology) 17 (4): 44-49.
Çelebi B, Mantovani D, Pineault N. (2011). Irradiated mesenchymal stem cells improve the ex vivo expansion of hematopoietic progenitors by partly mimicking the bone marrow endosteal environment. J Immunol Methods (Journal of Immunological Methods) 370 (1-2): 93-103.
Pineault N, Cortin V, Boyer L, Garnier A, Robert A, Thérien C, Roy DC. (2011). Individual and synergistic cytokine effects controlling the expansion of cord blood CD34+ cells and megakaryocyte progenitors in culture. Cytotherapy (Cytotherapy) 13 (04): 467-480.
Pineault N. (2011). Young maybe, but surely not immature. Blood (Blood) 117 (15): 3940-3941.
St-Louis M, Richard M, Côté M, Éthier C, Long A. (2011). Weak D type 42 cases found in individuals of European descent. Immunohematol (Immunohematology) 27 (1): 20-24.
Aubin É, Roberge C, Lemieux R, Bazin R. (2011). Immunomodulatory effects of therapeutic preparations of human albumin. Vox Sang (Vox Sanguinis) 101 (2): 131-137.
Néron S, Nadeau PJ, Darveau A, Leblanc JF. (2011). Tuning of CD40–CD154 Interactions in Human B-Lymphocyte Activation: A Broad Array of In Vitro Models for a Complex In Vivo Situation. Arch Immunol Ther Exp (Warsz) (Archivum Immunologiae et Therapiae Experimentalis) 59 (1): 25-40.
Faucher L, Guay-Bégin AA, Lagueux J, Côté MF, Petitclerc É, Fortin MA. (2011). Ultra-small gadolinium oxide nanoparticles to image brain cancer cells in vivo with MRI. Contrast Media Mol Imaging (Contrast Media & Molecular Imaging) 6 (4): 209-218.
Richard M, St-Laurent J, Perreault J, Long A, St-Louis M. (2011). A new SEMA7A variant found in Native Americans with alloantibody. Vox Sang (Vox Sanguinis) 100 (3): 322-326.
Robert A, Boyer L, Pineault N. (2011). Glycoprotein Ibα receptor instability is associated with loss of quality in platelets produced in culture. Stem Cells Dev (Stem Cells and Development) 20 (03): 379-390.